Intranasal immunotherapy for the treatment of Alzheimer’s disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants - Concepedia

Concepedia

Publication | Closed Access

Intranasal immunotherapy for the treatment of Alzheimer’s disease: Escherichia coli LT and LT(R192G) as mucosal adjuvants

70

Citations

61

References

2002

Year

Cynthia A. Lemere, E. T. C. Spooner, Jodi F. Leverone, Chica Mori, John D. Clements

Neurobiology of Aging

Mucosal VaccinationAlzheimer's DiseaseMicrobial PathogensMedicineAntibiotic AdjuvantImmunologyIntranasal ImmunotherapyMucosal AdjuvantsImmunotherapyNeuroimmunologyClinical Microbiology

References

	Year	Citations

Page 1